Health aspects of cannabis
- PMID: 3520605
Health aspects of cannabis
Abstract
Marijuana seems firmly established as another social drug in Western countries, regardless of its current legal status. Patterns of use vary widely. As with other social drugs, the pattern of use is critical in determining adverse effects on health. Perhaps the major area of concern about marijuana use is among the very young. Using any drug on a regular basis that alters reality may be detrimental to the psychosocial maturation of young persons. Chronic use of marijuana may stunt the emotional growth of youngsters. Evidence for an amotivational syndrome is largely based on clinical reports; whether marijuana use is a cause or effect is uncertain. A marijuana psychosis, long rumored, has been difficult to prove. No one doubts that marijuana use may aggravate existing psychoses or other severe emotional disorders. Brain damage has not been proved. Physical dependence is rarely encountered in the usual patterns of social use, despite some degree of tolerance that may develop. The endocrine effects of the drug might be expected to delay puberty in prepubertal boys, but actual instances have been rare. As with any material that is smoked, chronic smoking of marijuana will produce bronchitis; emphysema or lung cancer have not yet been documented. Cardiovascular effects of the drug are harmful to those with preexisting heart disease; fortunately the number of users with such conditions is minimal. Fears that the drug might accumulate in the body to the point of toxicity have been groundless. The potential deleterious effects of marijuana use on driving ability seem to be self-evident; proof of such impairment has been more difficult. The drug is probably harmful when taken during pregnancy, but the risk is uncertain. One would be prudent to avoid marijuana during pregnancy, just as one would do with most other drugs not essential to life or well-being. No clinical consequences have been noted from the effects of the drug on immune response, chromosomes, or cell metabolites. Contamination of marijuana by spraying with defoliants has created the clearest danger to health; such attempts to control production should be abandoned. Therapeutic uses for marijuana, THC, or cannabinoid homologs are being actively explored. Only the synthetic homolog, nabilone, has been approved for use to control nausea and vomiting associated with cancer chemotherapy.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Adverse effects of cannabis.Prescrire Int. 2011 Jan;20(112):18-23. Prescrire Int. 2011. PMID: 21462790 Review.
-
Adverse effects of cannabis on health: an update of the literature since 1996.Prog Neuropsychopharmacol Biol Psychiatry. 2004 Aug;28(5):849-63. doi: 10.1016/j.pnpbp.2004.05.027. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 15363608 Review.
-
Medical marijuana.West J Med. 1998 Jun;168(6):540-3. West J Med. 1998. PMID: 9656007 Free PMC article. Review.
-
Endocrine effects of marijuana in the male: preclinical studies.NIDA Res Monogr. 1984;44:46-64. NIDA Res Monogr. 1984. PMID: 6090909 Review.
-
[Adverse effects of marijuana].Rev Prat. 2005 Jan 15;55(1):41-9. Rev Prat. 2005. PMID: 15801396 Review. French.
Cited by
-
Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review.Int J Environ Res Public Health. 2022 Mar 8;19(6):3174. doi: 10.3390/ijerph19063174. Int J Environ Res Public Health. 2022. PMID: 35328862 Free PMC article. Review.
-
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.Pharmacol Res. 2007 Nov;56(5):360-6. doi: 10.1016/j.phrs.2007.09.003. Epub 2007 Sep 11. Pharmacol Res. 2007. PMID: 17945507 Free PMC article. Review.
-
Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments.Neurochem Res. 1993 Nov;18(11):1183-91. doi: 10.1007/BF00978372. Neurochem Res. 1993. PMID: 7504790
-
Marijuana. Respiratory tract effects.Clin Rev Allergy Immunol. 1997 Fall;15(3):243-69. doi: 10.1007/BF02737700. Clin Rev Allergy Immunol. 1997. PMID: 9358987 Review.
-
Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality.Int J Mol Sci. 2024 Jun 6;25(11):6268. doi: 10.3390/ijms25116268. Int J Mol Sci. 2024. PMID: 38892456 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials